The Coronavirus (COVID-19) Current Therapy Global Market Report 2023 by The Business Research Company, provides coronavirus (COVID-19) current therapy market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.
Learn More On The Coronavirus (COVID-19) Current Therapy Market:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
According to The Business Research Company’s Coronavirus (COVID-19) Current Therapy Global Market Report 2023, the market size grew from $16.43 billion in 2022 to $11.73 billion in 2023 at a compound annual growth rate (CAGR) of -28.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of the global coronavirus (covid-19) current therapy market is expected to grow to $1.05 billion in 2027 at a CAGR of -45.3%.
The outbreak of the pandemic COVID-19 contributed to the growth of the coronavirus (COVID-19) current therapy market. On March 11, 2020, the World Health Organization (WHO) declared the outbreak a global pandemic.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=3247&type=smp
The coronavirus (COVID-19) current therapy market is segmented:
1) By Drug Type: Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, Other Drug Type
2) By Route Of Administration: Oral, Intravenous
3) By End User: Hospitals, Clinics, Research Institutes, and Other End Users
Convalescent Plasma Therapy is used as an experimental therapy to treat COVID-19 patients. The blood plasma of patients who have recovered from a disease is called convalescent plasma (CP). Convalescent plasma therapy (CP) is a type of passive antibody therapy in which blood plasma is isolated from patients who have recovered from the disease of interest and administered to a patient with severe disease in order to suppress virulence and improve clinical symptoms. The blood plasma of recovered COVID-19 patients has antibodies to fight COVID-19 infection. According to guidance issued by the FDA, Convalescent Plasma Therapy is recommended as an investigational product during a public health emergency. By 30th April 2020, around 2,004 participating sites adhering to a single expanded access protocol by the US FDA had been registered, around 7,774 patients have enrolled, and 3,809 of them have undergone convalescent plasma transfusion. The experimental convalescent plasma therapy is likely to gain attention if enough data is supporting the results.
The coronavirus (COVID-19) current therapy market report table of contents includes:
.
.
.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The triazole fungicides market size is expected to see steady growth in the next few…
Overview and Scope Encapsulated flavors and fragrances refer to encapsulating or enclosing flavor and fragrance…
Overview and Scope An opto-isolator, often called an optical coupler or optocoupler, is an electronic…
Overview and Scope Military vetronics is the integration of electronics and computer systems into military…
The commercial satellite launch service market size is expected to see strong growth in the…
Overview and Scope Intravenous (IV) hydration therapy is a straightforward procedure that involves inserting a…